Levetiracetam: The preclinical profile of a new class of antiepileptic drugs?

Epilepsia

Volumn 42, Issue SUPPL. 4, 2001, Pages 13-18

  Klitgaard, H ^a  

^a UCB PHARMA   (Belgium)

Author keywords

Epilepsy; Levetiracetam; Seizure; Seizure models; ucb L059

Indexed keywords

CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; GABAPENTIN; LAMOTRIGINE; PENTETRAZOLE; PHENOBARBITAL; PHENYTOIN; TOPIRAMATE; VALPROIC ACID; VIGABATRIN;

ANIMAL MODEL; ANTICONVULSANT ACTIVITY; BINDING SITE; DRUG SAFETY; DRUG SCREENING; ELECTRIC SHOCK; ELECTROPHYSIOLOGY; EPILEPSY; EPILEPTOGENESIS; FOCAL EPILEPSY; KINDLING; LIGAND BINDING; NEUROTRANSMISSION; PRIORITY JOURNAL; REVIEW; SEIZURE;

EID: 0034864144     PISSN: 00139580     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1528-1157.2001.00003.x     Document Type: Review

References (28)

1. ucb L059, a novel anticonvulsant drug: Pharmacological profile in animals
2. Evidence for a unique profile of levetiracetam in rodent models of seizures and epilepsy
3. Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats
4. A permanent change in brain function resulting from daily electrical stimulation
5. Only certain antiepileptic drugs prevent seizures induced by pilocarpine
6. Kainic acid as a tool for the study of temporal lobe epilepsy
7. Limbic seizures produced by pilocarpine in rats: Behavioural, electroencephalographic and neuropathological study
8. Development of a new pharmacological seizure model: Effects of anticonvulsants on cortical- and amygdala-kindled seizures in the rat
9. Is amygdala kindling in rats a model for drug-resistant partial epilepsy?
10. Kindling: An animal model of complex partial epilepsy
11. Anticonvulsant efficacy of gabapentin and levetiracetam in phenytoin-resistant kindled rats
12. Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy
13. Anticonvulsant and behavioral effects of two novel competitive N-methyl-D-aspartic acid receptor antagonists, CGP 37849 and CGP 39551, in the kindling model of epilepsy. Comparison with MK-801 and carbamazepine
14. The excitatory amino acid antagonist D-CPP-ene (SDZ EAA-494) in patients with epilepsy
15. Absence of negative impact of levetiracetam on cognitive function and memory in normal and amygdala-kindled rats
16. Antiepileptogenic effects of the novel anticonvulsant levetiracetam (ucb L059) in the kindling model of temporal lobe epilepsy
17. Levetiracetam (ucb L059) affects in vitro models of epilepsy in CA3 pyramidal neurons without altering normal synaptic transmission
18. ucb L059, a novel anticonvulsant, reduces bicuculline-induced hyperexcitability in rat hippocampal CA3 in vivo
19. A receptor-associated epileptiform effect of bicuculline in rat hippocampus
20. Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs
21. Levetiracetam counteracts propagation of epileptiform activity induced by systemic administration of pilocarpine and kainic acid to rats in vivo
22. The novel antiepileptic drug levetiracetam (ucb L059) appears to act via a specific binding site in CNS membranes
23. 2+ currents
24. 2+ current in Ca1 pyramidal neurons of rat hippocampal slices
25. Effect of levetiracetam on voltage-gated potassium channels: A novel antiepileptic mechanism of action?
26. Levetiracetam: Novel modulation of ionotropic inhibitory receptors
27. Putnam, Merritt, and the discovery of Dilantin